Search results with tag "Cisplatin"
Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 66 Protocol: TIP (Paclitaxel/Ifosfamide/Cisplatin) Indications: Germ cell tumours – Recurrent
Protocol: CF (Cisplatin/5-Fluorouracil)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 103 Protocol: CF (Cisplatin/5-Fluorouracil) Indications: Head and neck – metastatic, recurrent
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Page 1 of 12 1 PRODUCT NAME CISPLATIN EBEWE® 1 mg/mL Solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains cisplatin 1 mg/mL 10mg in 10mL, 50mg in 50mL and 100mg in 100mL
Avastin® (Bevacizumab) – Medicare Advantage Policy Guideline
www.uhcprovider.como In combination with either a) paclitaxel and cisplatin or b) paclitaxel and topotecan in persistent, recurrent, or metastatic disease • Epithelial ovarian, fallopian tube, or primary peritoneal cancer ... o In combination with carboplatin and paclitaxel or …
DRUG NAME: Cisplatin
www.bccancer.bc.caThe table includes adverse events that presented d uring drug treatment but may not necessarily have a causal relationship with the drug. Because clinical trials …
Protocol: ABVD - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 86 Protocol: GDP (Gemcitabine/Dexamethasone/Cisplatin) Indications: Recurrent lymphoma and Hodgkin ...
Baxter Healthcare Corporation DOCETAXEL- docetaxel ...
www.baxterpi.commetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Docetaxel Injection in combination with cisplatin is indicated for the treatment of patients with
Protocol: Doxorubicin/Cisplatin - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 80 Protocol: Adjuvant DI (Doxorubicin/Ifosfamide) Indications: Soft tissue sarcomas – adjuvant ...
ESHAP (etoposide, methylprednisolone, cytarabine ...
www.londoncanceralliance.nhs.ukESHAP (etoposide, methylprednisolone, cytarabine & cisplatin) for Myeloma Page 1 of 2 Reason for Update: 2 year review Approved by Consultant: M Streetly 27/03/2013
Page 1 of 5 REGIMEN TITLE: TPF, Docetaxel, Cisplatin ...
www.londoncanceralliance.nhs.ukGFR should be calculated using the Cockcroft & Gault equation in all patients; if the calculated GFR < 60 or >120ml/min measure EDTA clearance or creatinine clearance
Chemotherapy Sequencing Guide – For therapies given on …
sites.mckesson.comBevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...
晚期泌尿上皮細胞癌的全身性治療 - nhri.org.tw
www.nhri.org.tw4 TCOG 通訊2010.4 專題研究 為每週1 次cisplatin 25 mg/m2/day。試驗 治療B 為引導式化學治療為3 個療程的PCF 處方，與放射治療同步進行的化學治療為每
Gem-Cisp: Gemcitabine/Cisplatin in Relapsed Ovarian ...
www.londoncanceralliance.nhs.ukReason for Update: Network Protocol Development Gemcitabine. should be used with caution in patients with impaired renal function: CrCl (ml/min) Gemcitabine Dose
Rx only PLATINOL
www.accessdata.fda.govFollowing cisplatin doses of 20 to 120 mg/m. 2, the concentrations of platinum are highest in liver, prostate, and kidney; somewhat lower in …
ANAL CANCER - Jones & Bartlett Learning
samples.jbpub.comBiliary Tract Cancer 7 Gemcitabine Cisplatin Baseline laboratory tests: CBC: Chemistry panel, LFTs, creatinine clearance, and CA 19-9 Baseline procedures or tests: N/A Initiate IV: 0.9% sodium chloride Premedicate: 5-HT 3 and dexamethasone 10–20 mg in 100 cc of NS Administer: Gemcitabine _____ mg (1250 mg/m2) IV on days 1 and 8 • Available in 1-g or 200-mg vials; reconstitute with 0.9% ...
ECF: Epirubicin / Cisplatin / PVI 5-Fluorouracil for ...
www.londoncanceralliance.nhs.ukReason for Update: Network Protocol Development . Fertility . Both male and female patients must use contraceptive methods to prevent conception
DRUG NAME: Carboplatin - BC Cancer
www.bccancer.bc.caCarboplatin Myelosuppression is the dose-limiting toxicity, usually manifested as thrombocytopenia and less commonly as leukopenia, neutropenia and anemia. Risk factors include prior cytotoxic therapy (especially cisplatin), poor performance status, old age, impaired renal function and concurrent myelosuppressive therapy.
Cisplatin
database.japic.or.jpする。これを1クールとして投与を繰り返す。 なお，I法の投与量は患者の状態により適宜減量する。
Similar queries
Protocol, 3-day Bleomycin/Etoposide/Cisplatin, Paclitaxel, Protocol: CF Cisplatin/5-Fluorouracil, NAME CISPLATIN, Cisplatin, DRUG NAME: Cisplatin, Table, ABVD, Gemcitabine, Cancer, Protocol: Doxorubicin/Cisplatin, Western, Protocols, Cytarabine, ESHAP etoposide, methylprednisolone, cytarabine & cisplatin, REGIMEN TITLE: TPF, Docetaxel, Cisplatin, Patients, Chemotherapy Sequencing Guide – For therapies, Rx only PLATINOL, Gemcitabine Cisplatin, DRUG NAME: Carboplatin